Valuation: Perrigo Company

Market Cap 2.21B 1.98B 1.83B 1.66B 3.1B 210B 3.15B 21.99B 8.7B 110B 8.31B 8.14B 347B P/E 2026 *
1,596x
P/E 2027 * 13.3x
Enterprise Value 5.12B 4.57B 4.22B 3.83B 7.16B 486B 7.28B 50.82B 20.12B 255B 19.21B 18.8B 803B EV / Sales 2026 *
1.26x
EV / Sales 2027 * 1.22x
Free-Float
99.61%
Yield 2026 *
7.25%
Yield 2027 * 7.44%
Manager TitleAgeSince
Chief Executive Officer 63 06/06/2026
Director of Finance/CFO 51 15/05/2022
Chief Operating Officer - 22/06/2025
Director TitleAgeSince
Director/Board Member 75 31/10/2014
Director/Board Member 61 06/11/2016
Director/Board Member 70 05/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
-2.54%+1.31%+55.10%+120.84% 1,135B
-1.42%+3.23%+37.07%+74.26% 636B
+0.16%+0.08%+25.14%+97.36% 505B
-0.31%+3.09%+43.92%+64.55% 378B
-1.34%-0.47%+66.63%+40.56% 358B
-0.68%+2.65%+22.46%+51.48% 295B
-1.20%+3.04%+2.62%+26.97% 266B
-1.79%+1.57%+49.97%+60.87% 237B
-0.73%-0.10%+29.24%+101.19% 193B
Average -0.67%+2.17%+36.91%+70.90% 444.93B
Weighted average by Cap. -0.26%+2.66%+40.99%+82.13%

Financials

2026 *2027 *
Net sales 4.05B 3.62B 3.34B 3.03B 5.67B 385B 5.76B 40.25B 15.93B 202B 15.21B 14.89B 636B 4.08B 3.65B 3.37B 3.05B 5.71B 388B 5.81B 40.54B 16.05B 203B 15.33B 15B 640B
Net income -224M -200M -185M -168M -313M -21.27B -319M -2.22B -881M -11.15B -841M -823M -35.14B -56.95M -50.86M -46.98M -42.58M -79.65M -5.41B -80.97M -565M -224M -2.83B -214M -209M -8.93B
Net Debt 2.9B 2.59B 2.4B 2.17B 4.06B 276B 4.13B 28.83B 11.42B 144B 10.9B 10.67B 455B 2.79B 2.49B 2.3B 2.08B 3.9B 265B 3.96B 27.66B 10.95B 139B 10.46B 10.24B 437B
Logo Perrigo Company
Perrigo Company plc is a pure-play self-care company. The Company provides health and wellness solutions. Its segments include Self Care, Specialty Care, and Infant Formula. Self Care comprises Upper Respiratory, Digestive Health, Pain & Sleep and Healthy Lifestyle product categories globally. Specialty Care comprises our Women's Health and Skin Health product categories globally. Infant Formula comprises the Infant Formula product category, which includes nutritional products designed to meet the dietary needs of infants. It provides a store-branded private label provider of self-care products in many categories, including upper respiratory, healthy lifestyle and women's health, along with brands including Opill and Mederma. Its Europe portfolio consists primarily of brands, including Compeed, ellaOne, Solpadeine, Jungle Formula, and ACO. Its upper respiratory products include Nasonex 24HR Energy, Mucus DM, All Day Allergy, Nighttime Cold & Flu, and Allergy Relief.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Perrigo Company